The first reported lncRNA with an aberrant expression in cancer was prostate cancer associated 3 (PCA3) (Bussemakers et al., 1999), which was identified via differential display analysis of transcripts in normal human prostate cancer. The gene discussed is PCA3; the disease is cancer.